ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

NCAB Member Becker Says AACR ‘Feels Disenfranchised’

December 6, 1991

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

Poll Finds Strong Support For Research; Yarbro Leads International Cancer Nurses.

October 6, 2000

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

NCI Budget: About Half Of Increase In President’s Budget Would Fund Grants

February 13, 1998

Armand Hammer Panel chairman; DeVita Announces Greenwald Appointment; Adamson To Be DCCP Director

October 9, 1981